9CF5
STRUCTURE OF CD4 MIMETIC CJF-III-288 IN COMPLEX WITH BG505 SOSIP.664 HIV-1ENV TRIMER AND 17B FAB
9CF5 の概要
| エントリーDOI | 10.2210/pdb9cf5/pdb |
| EMDBエントリー | 45530 |
| 分子名称 | Envelope glycoprotein gp120, Envelope glycoprotein gp41, 17b Fab light chain, ... (9 entities in total) |
| 機能のキーワード | hiv-1, fusion, entry, membrane, viral protein, viral protein-immune system complex, viral protein/immune system |
| 由来する生物種 | Human immunodeficiency virus 1 詳細 |
| タンパク質・核酸の鎖数 | 12 |
| 化学式量合計 | 371664.97 |
| 構造登録者 | |
| 主引用文献 | Richard, J.,Grunst, M.W.,Niu, L.,Diaz-Salinas, M.A.,Tolbert, W.D.,Marchitto, L.,Zhou, F.,Bourassa, C.,Yang, D.,Chiu, T.J.,Chen, H.C.,Benlarbi, M.,Gottumukkala, S.,Li, W.,Dionne, K.,Belanger, E.,Chatterjee, D.,Medjahed, H.,Hendrickson, W.A.,Sodroski, J.,Lang, Z.C.,Morton, A.J.,Huang, R.K.,Matthies, D.,Smith 3rd, A.B.,Mothes, W.,Munro, J.B.,Pazgier, M.,Finzi, A. The asymmetric opening of HIV-1 Env by a potent CD4 mimetic enables anti-coreceptor binding site antibodies to mediate ADCC. Biorxiv, 2024 Cited by PubMed Abstract: HIV-1 envelope glycoproteins (Env) from primary HIV-1 isolates typically adopt a pretriggered "closed" conformation that resists to CD4-induced (CD4i) non-neutralizing antibodies (nnAbs) mediating antibody-dependent cellular cytotoxicity (ADCC). CD4-mimetic compounds (CD4mcs) "open-up" Env allowing binding of CD4i nnAbs, thereby sensitizing HIV-1-infected cells to ADCC. Two families of CD4i nnAbs, the anti-cluster A and anti-coreceptor binding site (CoRBS) Abs, are required to mediate ADCC in combination with the indane CD4mc BNM-III-170. Recently, new indoline CD4mcs with improved potency and breadth have been described. Here, we show that the lead indoline CD4mc, CJF-III-288, sensitizes HIV-1-infected cells to ADCC mediated by anti-CoRBS Abs alone, contributing to improved ADCC activity. Structural and conformational analyses reveal that CJF-III-288, in combination with anti-CoRBS Abs, potently stabilizes an asymmetric "open" State-3 Env conformation, This Env conformation orients the anti-CoRBS Ab to improve ADCC activity and therapeutic potential. PubMed: 39253431DOI: 10.1101/2024.08.27.609961 主引用文献が同じPDBエントリー |
| 実験手法 | ELECTRON MICROSCOPY (3.5 Å) |
構造検証レポート
検証レポート(詳細版)
をダウンロード






